Ophthalmology Times - Ophthalmology news, articles, and events
WEBEfficacy of novel eye drop to reverse cataracts after phase 1/2 study. By Lynda Charters. August 25th 2024. The drop improves vision by breaking up degraded protein complexes that cause lens clouding. Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.
Physicians sort out pros and cons of several new IOLs on the market
WEBNov 12, 2021 · The new IOL in the EDoF category is the AcrySof IQ Vivity (Alcon). The Vivity uses wavefront-shaping technology on its anterior surface that elongates the depth of focus, giving about a 1.5 D range of vision. Because it is a nondiffractive lens, risks of glare and halos are minimized and quality of vision is better than with a multifocal IOL.
News - Ophthalmology Times
WEBSep 8, 2024 · Merck and EyeBio announce initiation of phase 2b/3 BRUNELLO trial evaluating MK-3000 for treatment of diabetic macular edema. September 5th 2024. MK-3000, formally known as EYE103, is an investigational, potentially first-in-class tetravalent, tri-specific antibody that acts as an agonist of the Wnt signaling pathway.
Ophthalmologists: Castor oil shouldn’t be rubbed in the eyes, no …
WEBAug 8, 2023 · Ophthalmologists are issuing a warning not to use castor oil as a way to treat vision problems amid claims circulating on TikTok. In its heyday, castor oil was considered a jack-of-all-trades home remedy, used as a laxative, a moisturizer and even as a chest rub to ease lung congestion. Now, it is making a comeback as some influencers on TikTok ...
Breaking down the dorzolamide shortage - Ophthalmology Times
WEBAug 9, 2019 · Essentially, brimonidine 0.1% (Alphagan P, Allergan) is often a reasonable substitution for dorzolamide, while brimonidine-timolol (Combigan, Allergan) is an ideal substitution for dorzolamide-timolol shortages, assuming no brimonidine allergy. Certainly, the dorzolamide shortage has helped us view branded pharmaceutical companies in a …
FDA approves eye drops for treatment of presbyopia
WEBOct 30, 2021 · Allergan developed VUITY, which it noted is the first and only FDA-approved eye drop to treat presbyopia. Allergan, an AbbVie company, announced FDA approval of pilocarpine HCl ophthalmic solution 1.25% (VUITY) for the treatment of presbyopia, commonly known as age-related blurry near vision, in adults. According to the company, …
Dispelling myths about refractive lens exchange - Ophthalmology …
WEBSep 7, 2020 · Ninety-nine percent of the responders considered themselves refractive surgeons and 34% had undergone a laser vision correction themselves. Almost 50% of those who underwent laser vision correction were in their 30s, 30% in their 40s, and 22% in their 20s at the time of surgery. Of the survey responders, 8.5% reported having …
The who, what, when, why and how of selective laser trabeculoplasty
WEBDec 1, 2015 · Laser trabeculoplasty is a minimally invasive laser therapy that helps regulate aqueous outflow. Selective laser trabeculoplasty (SLT) was approved by the United States Food and Drug Administration in 2001 and is currently the most commonly performed laser trabeculoplasty procedure because of its good safety profile.
Early clinical experience with next-generation lens
WEBMar 13, 2021 · Early clinical experience with next-generation lens. March 13, 2021. By Cheryl Guttman Krader, BS, Pharm. Publication. Article. Digital Edition Ophthalmology Times: March 15, 2021. Volume 46. Issue 5. One surgeon shares the early results of his experience using the new TECNIS Eyhance and TECNIS Eyhance Toric II IOLs in …
Identifying, managing dysphotopsia after cataract surgery
WEBApr 25, 2014 · Boston — Following cataract surgery, patients can present with a variety of visual complaints-i.e., dysphotopsias, aberrant optical phenomena that interfere with vision after IOL implantation. Positive dysphotopsias include rainbows, streaks, crescents, rings, halos, and veiling glare, haze, and fog. Negative dysphotopsias are relative and ...